23 results on '"Wenwen Ning"'
Search Results
2. Correlations between maternal hepatitis B virus carrier status and Down’s syndrome prenatal screening indicators and their effects on the screening results
- Author
-
Lingling Huang, Yiming Chen, Wenwen Ning, Yijie Chen, and Daojun Yu
- Subjects
Hepatitis B virus ,Obstetrics and Gynecology ,Chorionic Gonadotropin ,Pregnancy Trimester, First ,Pregnancy ,Prenatal Diagnosis ,Humans ,Pregnancy-Associated Plasma Protein-A ,Female ,Chorionic Gonadotropin, beta Subunit, Human ,alpha-Fetoproteins ,Down Syndrome ,Biomarkers ,Retrospective Studies - Abstract
The aim of this study was to determine the correlation between maternal hepatitis B virus (HBV) carrier status and pregnancy-associated serum screening indicators, as well as their implications on the prenatal screening results of Down's syndrome (DS). This retrospective cohort study included two groups, namely the healthy gravidas group (
- Published
- 2022
3. A retrospective cohort study on the effects of Down’s screening markers and maternal characteristics on pregnancy outcomes in preeclampsia
- Author
-
Bin Wu, Wenwen Ning, Yijie Chen, Caihe Wen, Huimin Zhang, and Yiming Chen
- Subjects
Fetal Growth Retardation ,Cesarean Section ,Physiology ,Pregnancy Outcome ,Hydronephrosis ,General Medicine ,Cicatrix ,Pregnancy Trimester, First ,Pre-Eclampsia ,Pregnancy ,Prenatal Diagnosis ,Internal Medicine ,Humans ,Pregnancy-Associated Plasma Protein-A ,Premature Birth ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Down Syndrome ,Biomarkers ,Retrospective Studies - Abstract
To investigate the effects of down's screening markers and maternal characteristics on preeclampsia (PE) pregnancy outcome during early and middle pregnancy.A retrospective study of a cohort of 246 PE and 18,709 No-PE pregnant women who participated in Down's screening during early and middle pregnancy was performed. Clinical data of pregnancy-related were collected. Multivariate binary logistic regression was used to analyze the adjusted odds ratio (aOR) and 95% confidence interval (CI) of Down's screening markers, maternal characteristics, pregnancy outcome, and other related variables, and to evaluate the influencing factors of each indicator on PE.Compared with the non-PE group, the concentration and median multiple (MoM) of pregnancy-associated plasma protein-A (PAPP-A) and free beta subunit of human chorionic gonadotropin (free β-hCG) in PE group were both lower (Decreased maternal serum PAPP-A level, increased free β-hCG, hyperlipemia, premature delivery, cesarean section, live birth, hydronephrosis, fetal growth retardation, low birth weight, and infection are risk factors for PE, while uterine scar and premature rupture of membrane are protective factors for PE.
- Published
- 2022
4. The importance of the trisomy 21 local cutoff value evaluation for prenatal screening in the second trimester of pregnancy
- Author
-
Chen Yiming, Yijie Chen, Long Sun, Liyao Li, and Wenwen Ning
- Subjects
Biochemistry (medical) ,Clinical Biochemistry - Abstract
Objective The aim of this work was to compare different local cutoff values (LCV) and inline cutoff values (ICV) in pregnant women in the second trimester at high risk for carrying fetuses with trisomy 21. Methods This retrospective cohort study analyzed prenatal screening outcomes in pregnant women (n = 311,561). The receiver operating characteristic curve was used to evaluate the diagnostic significance of the trisomy 21 risk value, alpha-fetoprotein, and free beta human chorionic gonadotropin multiple of the median for predicting trisomy 21 risk. The cutoff value corresponding to the maximal Youden index was taken as the LCV. The screening efficiency of both cutoff values was compared. Results The LCV cutoff value was lower than the ICV cutoff value (1/643 vs 1/270). The sensitivity increased by 19.80%, the positive predictive value decreased by 0.20%, and the false-positive rate increased by 6.50%. Conclusion The LCV should be used to determine trisomy 21 risk, which can increase the detection rate of trisomy 21 in the second trimester.
- Published
- 2023
5. Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study
- Author
-
Xiaoqing Dai, Huimin Zhang, Bin Wu, Wenwen Ning, Yijie Chen, and Yiming Chen
- Subjects
Physiology ,Internal Medicine ,General Medicine - Published
- 2023
6. Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects
- Author
-
Yiming Chen, Xue Wang, Yijie Chen, WenWen Ning, Lei Chen, Yixuan Yin, Wen Zhang, Jiejing Lian, and Hao Wang
- Subjects
Fetus ,Pregnancy ,Case-Control Studies ,Prenatal Diagnosis ,Humans ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Neural Tube Defects ,alpha-Fetoproteins ,Biomarkers ,General Biochemistry, Genetics and Molecular Biology ,Retrospective Studies ,Original Research - Abstract
The correlation of maternal serum alpha-fetoprotein (AFP) variants (AFP-L2, AFP-L3), free beta-human chorionic gonadotropin (free β-hCG), and open neural tube defects (ONTDs) during the second trimester, and the screening efficiency of different risk models remain indistinct. We conducted a retrospective case-control study, and studied 57 pregnant women with ONTD fetuses and 569 pregnant women with normal fetuses. The receiver operating characteristic curve method indicated the best cutoff value and area under the curve (AUC). The predictive value of ONTD risk models by free β-hCG, AFP, AFP-L2, and AFP-L3 was investigated via integrated discrimination improvement (IDI), net reclassification improvement (NRI), and decision curve analysis (DCA). Compared to the control group, AFP, AFP-L2, and AFP-L3 levels were significantly higher, while free β-hCG level was significantly lower in the study group. The triple-index model of free β-hCG + AFP-L2 + AFP-L3 and the dual-index model of AFP-L2 + AFP-L3 showed the best predictive values, respectively (AUC = 0.905; AUC = 0.885). The order of the single-index model AUCs was AFP-L3 > AFP-L2 > AFP > free β-hCG. The negative predictive value, false positive rate, and negative likelihood ratio of AFP-L2, AFP-L3 alone, or combined with free β- hCG were better than those of AFP alone; however, the positive likelihood ratio was the opposite. The replacement of AFP by AFP-L2 or AFP-L3 combined with free β-hCG increased the IDI and NRI for predicting ONTD. The top five DCAs were AFP-L2 + free β-hCG, free β-hCG, AFP-L3, AFP + free β-hCG, and AFP. Indicators of maternal serum free β-hCG, AFP-L2, and AFP-L3 in the second trimester exhibited high sensitivity and specificity screening for ONTD fetuses. Risk models constructed using AFP-L2 + AFP-L3 and AFP-L2 + AFP-L3 + free β-hCG demonstrated better screening efficiency.
- Published
- 2022
7. The impact of intrahepatic cholestasis on pregnancy outcomes: a retrospective cohort study
- Author
-
Yiming Chen, Huimin Zhang, Wenwen Ning, Yijie Chen, and Caihe Wen
- Subjects
Gastroenterology ,General Medicine - Abstract
Background This study analyzed the pregnancy outcomes of patients with intrahepatic cholestasis of pregnancy (ICP) in Hangzhou, China. Methods Cases of pregnant women monitored by antepartum testing at Hangzhou Women’s Hospital from January 2018 to December 2020 were reviewed. Subjects were classified into two groups according to whether they had ICP: 688 cases of ICP were assigned to an exposure group while 38,556 cases of non-ICP were assigned to a non-exposed group. Univariate analysis was performed on qualitative or quantitative data using the Chi-Squared test or Mann–Whitney U test, and the adjusted odds ratio (aOR) and 95% confidence interval (CI) of the two groups of related variables were calculated by multivariate binary logistic regression analysis. Results The incidence rate of ICP was 1.75%. Pregnant women with hepatitis B virus were correlated with ICP. Hepatitis B carriers (aOR = 3.873), preeclampsia (PE, aOR = 3.712), thrombocytopenia (aOR = 1.992), gestational hypertension (GH, aOR = 1.627), hyperlipidemia (aOR = 1.602) and gestational diabetes mellitus (GDM, aOR = 1.265) were all risk factors for ICP. In contrast, Body Mass Index (BMI) ≥ 30 kg/m2 (aOR = 0.446), 25 m2 2 (aOR = 0.699) and parity ≥ 1 (aOR = 0.722) were protective factors for ICP. Pregnant women in the ICP group had an increased risk of gestation days Conclusions By analyzing a Chinese population with ICP, we identified that pregnant women who are hepatitis B carriers or with PE, thrombocytopenia, GH, hyperlipidemia, and GDM are at higher risk of ICP. Moreover, ICP is associated with adverse pregnancy outcomes; in particular, ICP may increase the incidence of shorter gestational days and non-vaginal delivery methods such as cesarean section but reduce the incidence of premature rupture of membranes and fetal macrosomia.
- Published
- 2023
8. A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy
- Author
-
Yijie Chen, Huimin Zhang, Yiming Chen, Wenwen Ning, and Bin Wu
- Subjects
medicine.medical_specialty ,medicine.drug_class ,Trisomy ,Gastroenterology ,Fetus ,Pregnancy ,Serum biomarkers ,Prenatal Diagnosis ,Internal medicine ,medicine ,Humans ,Pregnancy-Associated Plasma Protein-A ,Chorionic Gonadotropin, beta Subunit, Human ,Retrospective Studies ,business.industry ,Area under the curve ,Obstetrics and Gynecology ,medicine.disease ,Blood proteins ,Pregnancy Trimester, First ,Case-Control Studies ,Biomarker (medicine) ,Female ,alpha-Fetoproteins ,Down Syndrome ,Gonadotropin ,business ,Alpha-fetoprotein ,Biomarkers - Abstract
To establish a risk prediction model and the clinical value of trisomy 21 using alpha-fetoprotein variants L2 (AFP-L2) combined with maternal serum biomarkers and nuchal translucency (NT) thickness in early pregnancy. A retrospective case–control study was conducted. The subjects were divided into the case group (n = 40) or the control group (n = 40). An enzyme-linked immunosorbent assay was used to measure the maternal serum AFP-L2 level in both groups. The AFP-L2 single-index or multi-index combined risk model was used to predict the efficiency of trisomy 21. The best cut-off value and area under the curve (AUC) were determined to evaluate the predictive efficacy of different risk models constructed by AFP-L2. The maternal serum AFP-L2 level in the case group was 1.59 (0.61–3.61) Multiple of medium (MoM), which was higher than 1.00 (0.39–2.12) MoM in the control group (P P P
- Published
- 2021
9. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
- Author
-
Yiming Chen, Yijie Chen, Wenwen Ning, Wen Zhang, Liyao Li, Xiaoying Wang, Yixuan Yin, and Huimin Zhang
- Subjects
Multidisciplinary ,Pregnancy ,Pregnancy Trimester, Second ,Prenatal Diagnosis ,Humans ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Trisomy ,alpha-Fetoproteins ,Down Syndrome ,Biomarkers ,Trisomy 18 Syndrome - Abstract
To evaluate the clinical predictive value of serum alpha-fetoprotein variants (AFP-L2, AFP-L3) in combination with maternal serum prenatal screening biomarkers in predicting fetal trisomy 21 and trisomy 18. We analyze the data of singleton pregnant women at 15–20+6 weeks of 731,922 gravidas from October 2007 to September 2019. The research objects were separated into the following groups: control (n = 569), trisomy 21 (n = 116), and trisomy 18 (n = 52). The cases were diagnosed by chromosomal karyotypic analysis of amniotic fluid cells. Level of AFP-L2 and AFP-L3 were detected in maternal serum among control women and patients. Receiver operator characteristic analysis, detection rate, false positive rate, false negative rate, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio, comprehensive discriminant improvement, net weight classification improvement, decision curve analysis and Hosmer–lemeshow (H-L) test were used to investigate the predictive value of free β-hCG, AFP, AFP-L2 and AFP-L3 on the risk models of trisomy 21, 18. There was a statistically significant difference in maternal serum AFP-L2 and AFP-L3 multiple of the median (MoM) among the trisomy 21, trisomy 18, and control groups. The AUCs of AFP-L2 and AFP-L3 for the screening trisomy 21 and trisomy 18 fetus were 0.785, 0.758 and 0.775, 0.754. According to ROC, the optimal cut-off values of AFP-L2 and AFP-L3 for predicting trisomy 21 and trisomy 18 fetuses all were 1.09 MoM and 1.30 MoM, respectively. The risk-calculation model constructed by AFP-L2 + AFP-L3 MoM manifested better efficiency than the original single-value truncation method using AFP MoM alone. Compared with different modeling methods, the AUC of trisomy 21 fetuses predicted by AFP-L2 + AFP-L3 + free β-hCG achieved an optimal value (0.938), while the AUC of trisomy 18 fetus predicted by AFP-L2 + free β-hCG was the best (0.991). Compared with AFP, the IDI of AFP-L2 or AFP-L3 alone increased 9.56% and 12.34%; the NRI increased 26.50% and 26.70 in predicting trisomy 21. For trisomy 18, the IDI of AFP-L2 or AFP-L3 alone declined with 8.12% and 1.52%; the NRI declined with 13.84% and 8.54%. In the combined model, the model with best detection rate, false positive rate and positive likelihood ratio was AFP-L2 + AFP-L3 + free β-hCG, followed by AFP-L2 + free β-hCG and AFP-L3 + free β-hCG, and finally AFP + free β-hCG. Maternal serum AFP-L2 and AFP-L3 in the second trimester is a good marker for screening trisomy 21 and trisomy18 with high sensitivity and specificity. The combined screening results are better than the single marker, and the efficiency of AFP-L2 + AFP-L3 + free β-hCG is the best.
- Published
- 2022
10. A risk model that combines MAP, PlGF, and PAPP-A in the first trimester of pregnancy to predict hypertensive disorders of pregnancy
- Author
-
Yiming Chen, Zhi-Fen Zhang, Xue Wang, Li Liyao, Yijie Chen, He Pei, Wensheng Hu, Wenwen Ning, and Sha Lu
- Subjects
Placental growth factor ,Gestational hypertension ,medicine.medical_specialty ,Mean arterial pressure ,Pregnancy ,business.industry ,Obstetrics ,Multiple of the median ,030204 cardiovascular system & hematology ,medicine.disease ,Blood proteins ,Preeclampsia ,03 medical and health sciences ,0302 clinical medicine ,Internal Medicine ,Medicine ,Cutoff ,030212 general & internal medicine ,business - Abstract
Whether the first trimester maternal mean arterial pressure (MAP), placental growth factor (PlGF), and pregnancy-associated plasma protein A (PAPP-A) can predict hypertensive disorders of pregnancy (HDP) is unclear. We conducted a retrospective case–control study with the total population of 539 gravidas, of these 447 had normal pregnancy, 27 had gestational hypertension (GH), 36 had preeclampsia (PE), and 29 had preeclampsia with severe features (SPE). Prediction for HDP was determined by the area under curve (AUC). Compared to the healthy group, the multiple of the median (MoM) for MAP was increased in the study groups, while PlGF and PAPP-A were decreased. When the cutoff values for MAP, PlGF, and PAPP-A were 1.069, 0.769, and 0.673 MoM, respectively, the sensitivities for predicting HDP were 0.517, 0.446, and 0.500 and the specificities were 0.744, 0.826, and 0.769, respectively. To predict GH, the highest AUC was 0.755 (95% CI: 0.655–0.856, p
- Published
- 2021
11. Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
- Author
-
Yiming Chen, Wenwen Ning, Yezhen Shi, Yijie Chen, Wen Zhang, Liyao Li, and Xiaoying Wang
- Subjects
Multidisciplinary - Abstract
Objective To determine the efficacy of three different maternal screening programs (first-trimester screening [FTS], individual second-trimester screening [ISTS], and first- and second-trimester combined screening [FSTCS]) in predicting offspring with trisomy 21, trisomy 18, and neural tube defects (NTDs). Methods A retrospective cohort involving 108,118 pregnant women who received prenatal screening tests during the first (9–13+6 weeks) and second trimester (15–20+6 weeks) in Hangzhou, China from January–December 2019, as follows: FTS, 72,096; ISTS, 36,022; and FSTCS, 67,631 gravidas. Result The high and intermediate risk positivity rates for trisomy 21 screening with FSTCS (2.40% and 5.57%) were lower than ISTS (9.02% and 16.14%) and FTS (2.71% and 7.19%); there were statistically significant differences in the positivity rates among the screening programs (all P < 0.05). Detection of trisomy 21 was as follows: ISTS, 68.75%; FSTCS, 63.64%; and FTS, 48.57%. Detection of trisomy 18 was as follows; FTS and FSTCS, 66.67%; and ISTS, 60.00%. There were no statistical differences in the detection rates for trisomy 21 and 18 among the 3 screening programs (all P > 0.05). The positive predictive values (PPVs) for trisomy 21 and 18 were highest with FTS, while the false positive rate (FPR) was lowest with FSTCS. Conclusion FSTCS was superior to FTS and ISTS screening and substantially reduced the number of high risk pregnancies for trisomy 21 and 18; however, FSTCS was not significantly different in detecting fetal trisomy 21 and 18 and other confirmed cases with chromosomal abnormalities.
- Published
- 2023
12. Maternal hepatitis B surface antigen Carrier Status and Pregnancy Outcome: A Retrospective Cohort Study
- Author
-
Yiming Chen, Wenwen Ning, Xue Wang, Yijie Chen, Bin Wu, and Jie Tao
- Subjects
Infectious Diseases ,Epidemiology - Abstract
To investigate the effect of maternal hepatitis B surface antigen (HBsAg) carrier status during pregnancy on pregnancy outcomes in a population of patients in Hangzhou, China. A retrospective cohort study was conducted to analyse data from 20 753 pregnant women who delivered at Hangzhou Women's Hospital between January 2015 and March 2020. Of these, 18 693 were normal pregnant women (the non-exposed group) and 735 were HBsAg carriers (the exposed group). We then analysed by binary multivariate logistic regression to determine the association between maternal HBsAg-positive and adverse pregnancy outcomes. The prevalence of HBsAg carriers was 3.78% and the odds ratio (OR) for maternal age in the exposed group was 1.081. Pregnant women who are HBsAg-positive in Hangzhou, China, are at higher risk of a range of adverse pregnancy outcomes, including intrahepatic cholestasis of pregnancy (ICP) (adjusted OR (aOR) 3.169), low birth weight (aOR 2.337), thrombocytopenia (aOR 2.226), fallopian cysts (aOR 1.610), caesarean scar pregnancy (aOR 1.283), foetal distress (aOR 1.414). Therefore, the obstetricians should pay particular attention to ICP, low birth weight, thrombocytopenia, fallopian cysts, caesarean scar, foetal distress in HBsAg-positive pregnant women.
- Published
- 2022
13. External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days
- Author
-
Yiming Chen, Yijie Chen, Yezhen Shi, Wenwen Ning, Xiaoying Wang, Liyao Li, and Huimin Zhang
- Subjects
Estriol ,Pregnancy ,Pregnancy Trimester, Second ,Prenatal Diagnosis ,Humans ,Reproducibility of Results ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,General Medicine ,Neural Tube Defects ,alpha-Fetoproteins ,Down Syndrome ,Biomarkers - Abstract
BACKGROUND We aimed to insure the accuracy and reproducibility of alpha-fetoprotein (AFP), free beta-human chorionic gonadotropin (free ß-hCG), and unconjugated estriol (uE3) concentrations for the screening for trisomy 21 (T21) and neural tube defects (NTD) in the second trimester. We conducted an external quality assessment of 6 laboratories, using maternal serum specimens. MATERIAL AND METHODS Serum specimens collected from 87 women of singleton pregnancies (4 with T21, 5 with NTD, and 78 with normal fetuses) were divided into 6 equivalent-volume fractions and transported to 6 laboratories (A, B, C, D, E, and F). All laboratories used the time-resolved fluorescence analyzer and supporting reagents to measure concentrations of AFP, free ß-hCG, and uE3. The screening efficacies of T21 and NTD were compared with the certified or accredited status of the participants' quality systems. RESULTS Concentrations of AFP measured by laboratory F were low compared with those determined by the other 5 laboratories, and the differences were significant (P0.01). There was no statistically significant difference in the free ß-hCG and uE3 concentrations measured by the 6 laboratories (P0.05). The correlation coefficients for the 3 multiples of the median values were all0.900. The McNemar paired chi-squared test showed the differences in the positivity and detection rates were not statistically significant (P=1.000). CONCLUSIONS AFP, free ß-hCG, and uE3 values measured by the other 5 laboratories were comparable with those of laboratory A, with good linear correlation. When used in the maternal prenatal screening of T21 and NTD, the test results met the clinical requirements.
- Published
- 2022
14. Role of microRNAs regulating trophoblast cell function in the pathogenesis of pre‑eclampsia (Review)
- Author
-
Wenwen Ning, Bin Wu, Yijie Chen, Jiejing Lian, and Yiming Chen
- Subjects
Cancer Research ,Immunology and Microbiology (miscellaneous) ,General Medicine - Abstract
Pre-eclampsia (PE) is a complicated pregnancy-specific disease and is considered the primary reason for maternal and foetal mortality and morbidity. PE has a multifactorial pathogenesis but the causes of PE remain unclear. The functions of trophoblasts, including differentiation, proliferation, migration, invasion and apoptosis, are essential for successful pregnancy. During the early stages of placental development, trophoblasts are strictly regulated by several molecular pathways; however, an imbalance of these molecular pathways can lead to severe placental lesions and pregnancy complications. Certain microRNAs (miRs) are abnormally expressed in PE, with several miRs involved in the regulation of pregnancy-associated genes. The present review discusses the miRs regulating trophoblast function, how they affect the pathogenesis of PE and evaluating the possibility of miRs in screening, diagnosis and treatment of PE.
- Published
- 2022
15. Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free β-Subunit of Human Chorionic Gonadotropin, and Fetal Nuchal Translucency
- Author
-
Yiming Chen, Wenwen Ning, Xuelian Chu, Yijie Chen, Linyuan Gu, Zhen Xie, Liyao Li, Caihe Wen, and Xiaoying Wang
- Subjects
General Immunology and Microbiology ,Article Subject ,General Medicine ,General Biochemistry, Genetics and Molecular Biology - Abstract
We aimed to investigate the predictive ability of serum levels of D-dimer (DD) in the first trimester for the occurrence of hypertensive disorders of pregnancy (HDP). In this retrospective, case-cohort study, we measured the levels of DD, plasma pregnancy-associated protein A (PAPP-A), and free β-subunit of human chorionic gonadotropin (free β-hCG) and analyzed fetal nuchal translucency (NT) in 150 healthy gravidas, 126 cases of gestational hypertension (GH), 53 cases of preeclampsia (PE), and 41 cases with severe preeclampsia (SPE). Likelihood ratio models and risk models were built using single markers (DD, PAPP-A, free β-hCG, and NT) and combinations of those markers. Analyses showed that the levels of DD multiple of the median (MoM) in the GH, PE, and SPE groups were all significantly higher than those in the control group, with significant differences between groups ( χ 2 = 70.325 , P < 0.001 ). The area under curve (AUCs) for DD in the GH, PE, and SPE groups was 0.699, 0.784, and 0.893, respectively; the positive likelihood ratio (+LR) was 1.534, 1.804, and 2.941, respectively; and the negative likelihood ratio (-LR) was 0.022, 0.081, and 0, respectively. When the cut-off values of DD for the GH, PE, and SPE groups were 0.725, 0.815, and 0.945 MoM, respectively, the corresponding sensitivities were 0.992, 0.962, and 1.000, respectively. As gestational hypertension progressed, the levels of DD tended to increase gradually. The maternal serum level of DD in the first trimester had correlative and diagnostic value for HDP. The sensitivity and specificity of maternal serum levels of DD level in the first trimester for different types of HDP were significantly different; the best sensitivity and specificity were detected in the SPE group. First trimester DD level, combined with other biochemical markers, may improve our ability to diagnose HDP.
- Published
- 2022
- Full Text
- View/download PDF
16. Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free
- Author
-
Yiming, Chen, Wenwen, Ning, Xuelian, Chu, Yijie, Chen, Linyuan, Gu, Zhen, Xie, Liyao, Li, Caihe, Wen, and Xiaoying, Wang
- Subjects
Hypertension, Pregnancy-Induced ,Chorionic Gonadotropin ,Cohort Studies ,Fibrin Fibrinogen Degradation Products ,Pregnancy Trimester, First ,Pre-Eclampsia ,Pregnancy ,Prenatal Diagnosis ,Humans ,Pregnancy-Associated Plasma Protein-A ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Nuchal Translucency Measurement ,Staphylococcal Protein A ,Biomarkers ,Retrospective Studies - Abstract
We aimed to investigate the predictive ability of serum levels of D-dimer (DD) in the first trimester for the occurrence of hypertensive disorders of pregnancy (HDP). In this retrospective, case-cohort study, we measured the levels of DD, plasma pregnancy-associated protein A (PAPP-A), and free
- Published
- 2021
17. Ultrasound findings in prenatal diagnosis of trisomy 18 associated with elevated levels of maternal serum alpha-fetoprotein
- Author
-
Yiming Chen, Wenwen Ning, Yijie Chen, Lei Huai, and Anqian Huang
- Published
- 2022
18. Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18
- Author
-
Wenwen Ning, Yijie Chen, Yiming Chen, Wensheng Hu, Hao Wang, Huang Jianxia, and Li Wen
- Subjects
medicine.medical_specialty ,Trisomy ,03 medical and health sciences ,0302 clinical medicine ,Fetus ,Second trimester ,Pregnancy ,Prenatal Diagnosis ,medicine ,Humans ,Chorionic Gonadotropin, beta Subunit, Human ,030212 general & internal medicine ,neoplasms ,Retrospective Studies ,Obstetrics ,business.industry ,digestive, oral, and skin physiology ,Obstetrics and Gynecology ,medicine.disease ,humanities ,digestive system diseases ,030220 oncology & carcinogenesis ,Case-Control Studies ,embryonic structures ,Pediatrics, Perinatology and Child Health ,Female ,alpha-Fetoproteins ,Alpha-fetoprotein ,business ,Trisomy 18 Syndrome - Abstract
To evaluate the effectiveness of alpha-fetoprotein variants (AFP-L2, AFP-L3) in fetal screening for Trisomy 18 in place of alpha fetoprotein (AFP).A retrospective case-control study was conducted. Collectively, 39 pregnant women bearing Trisomy 18 fetuses and 48 pregnant women with clinically normal and healthy fetuses were included. The serum AFP-L2 and AFP-L3 concentrations were detected by enzyme-linked immunosorbent assays. The likelihood ratio method and Python software were used to construct the risk model with AFP, free β-hCG, AFP-L2, and AFP-L3 to predict Trisomy 18. Receiver operating characteristic (ROC) curves were used to determine the optimal cutoff value, while the area under the curve (AUC) was used to assess the screening performance of AFP-L2 and AFP-L3 for fetal Trisomy 18.Compared to values observed for the control group, AFP-L2 and AFP-L3 concentrations which were significantly higher (bothAFP-L2 and AFP-L3 showed higher sensitivity and specificity as substitutes for AFP in screening Trisomy 18. These two markers indeed improved the screening efficiency and reduced the false positive rate, when compared with AFP only.
- Published
- 2021
19. Effect of surfactants on the performance of 3D morphology W18O49 by solvothermal synthesis
- Author
-
Zhanyong Gu, Shu Yin, Yu Bai, Jimin Fan, Zhihuan Zhao, Honghong Chang, and Wenwen Ning
- Subjects
Materials science ,Solvothermal synthesis ,General Physics and Astronomy ,02 engineering and technology ,Surfaces and Interfaces ,General Chemistry ,010402 general chemistry ,021001 nanoscience & nanotechnology ,Condensed Matter Physics ,01 natural sciences ,0104 chemical sciences ,Surfaces, Coatings and Films ,Solvent ,chemistry.chemical_compound ,chemistry ,Pulmonary surfactant ,X-ray photoelectron spectroscopy ,Chemical engineering ,Bromide ,Phase (matter) ,Transmittance ,Lamellar structure ,0210 nano-technology - Abstract
Three-dimensional W18O49 nanostructures were synthesized by a solvothermal method using WCl6 as precursor and ethanol as solvent. The effects of surfactant on the crystalline phase and morphology of tungsten oxide were investigated. It was found that the photothermal conversion performance and the nanostructures were affected by the surfactant additives. The results of XRD, SEM, TEM, BET and XPS indicated that the addition of surfactant had no effect on the composition of the samples, while the morphology of the sample changed from the irregular massive structure to the uniform polygon, lamellar or nest structures. The results of DRS and heat resistance test showed that the film had excellent infrared shielding properties. The sample synthesized by the adding of cetyltrimethylammonium bromide (CTAB) surfactant showed only 34.04% transmittance in the infrared wavelength range, while the transmittance maintained at high level of 77.5% in the visible range. It reached to higher heat resistance of 6.5 °C under 1 h sunlight irradiation than other samples, the temperature change was only 41.7% of the blank test.
- Published
- 2019
20. Second-trimester prenatal diagnosis of trisomy 18 associated with elevated maternal serum alpha-fetoprotein level, bilateral multiple choroid plexus cysts, cleft lip and palate, and atrioventricular septal defect, and review of the literature
- Author
-
Yiming Chen, Lei Huai, Anqian Huang, Wenwen Ning, and Yijie Chen
- Subjects
Pathology ,medicine.medical_specialty ,Text mining ,business.industry ,Second trimester ,Medicine ,Prenatal diagnosis ,Choroid plexus ,Atrioventricular Septal Defect ,business ,Elevated maternal serum alpha-fetoprotein ,Trisomy ,medicine.disease - Abstract
Objective: To present the prenatal diagnosis of trisomy 18 and to review of the literature. Case: A 29-year-old pregnant woman was showed high risk of trisomy 18 by maternal serum screening at 16 weeks' of gestation, showing elevated AFP(125 U/mL, 3.25 MoM), low free β-hCG (3.29 ng/mL,0.11MoM), low PAPP-A (1120 mU/L, 0.31MoM). She asked for an amniocentesis because the risk value for trisomy 18 was 1/5 and trisomy 21 was 1/77121. Results: The results of amniocentesis on Prenatal BoBs revealed a fetus with trisomy 18, whose karyotype of amniotic fluid cells was 47, XY, +18. Ultrasonography demonstrated intrauterine pregnancy, single live fetus, multiple abnormalities including "strawberry head ", bilateral multiple choroid plexus cysts, cleft lip and palate, and atrioventricular septal defect. The pregnancy was terminated subsequently. Conclusion: Trisomy 18 can be identified in prenatal screening with advanced maternal age, abnormal maternal serum screen results, and multi-structural abnormal ultrasonography results. Fetuses with trisomy 18 may be associated with congenital heart disease, neural tube malformation, abdominal valgus, omphalocele, multiple cysts in bilateral choroid plexus, cleft lip and palate, elevated AFP, and decreased free β-hCG and PAPP-A.
- Published
- 2021
21. Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case–control study
- Author
-
Gu Linyuan, Caihe Wen, Xie Zhen, Yijie Chen, Wenwen Ning, Yiming Chen, Xue Wang, Li Liyao, and Chu Xuelian
- Subjects
Gestational hypertension ,medicine.medical_specialty ,lcsh:Medicine ,030204 cardiovascular system & hematology ,Likelihood ratios in diagnostic testing ,Gastroenterology ,Chorionic Gonadotropin ,General Biochemistry, Genetics and Molecular Biology ,Preeclampsia ,Human chorionic gonadotropin ,Fibrin Fibrinogen Degradation Products ,03 medical and health sciences ,0302 clinical medicine ,Pre-Eclampsia ,Pregnancy ,Internal medicine ,Prenatal Diagnosis ,D-dimer ,medicine ,Humans ,Retrospective Studies ,030219 obstetrics & reproductive medicine ,Receiver operating characteristic ,business.industry ,Research ,lcsh:R ,General Medicine ,Hypertension, Pregnancy-Induced ,medicine.disease ,Hypertensive disorders of pregnancy ,Case-Control Studies ,Pregnancy Trimester, Second ,Alpha-fetoprotein ,Female ,Free β subunit of human chorionic gonadotropin ,alpha-Fetoproteins ,business ,Biomarkers - Abstract
Background This study investigated whether maternal serum D-dimer (DD) alone or DD combined with alpha-fetoprotein (AFP) and free β-subunit of human chorionic gonadotropin (free β-hCG) in the second trimester could be used to predict hypertensive disorders of pregnancy (HDP). Materials and methods In this retrospective case–control study, the data of gravidas patients who delivered at hospital were divided into the following groups: control (n = 136), gestational hypertension (GH, n = 126), preeclampsia (PE, n = 53), and severe preeclampsia (SPE, n = 41). Receiver operator characteristic (ROC) curves were used to evaluate the diagnostic value of maternal serum DD, AFP, and free β-hCG levels for HDP. Results DD levels of the GH, PE, and SPE groups were significantly higher than that of the control group (P DD > DD + AFP > DD + free β-hCG > AFP + free β-hCG > AFP > free β-hCG. For predicting different types of HDP, DD alone had the best diagnostic value for SPE, followed by PE and GH. DD alone had a sensitivity of 100% with a 0% false negative rate and had the highest positive likelihood ratio (+ LR) for SPE. DD alone in combination with AFP alone, free β-hCG alone and AFP + free β-hCG could reduce false positive rate and improve + LR. Conclusion DD is possible the best individual predictive marker for predicting HDP. Levels of DD alone in the second trimester were positively correlated with the progression of elevated blood pressure in the third trimester, demonstrating the predicting the occurrence of HDP. The risk calculation model constructed with DD + free β-hCG + AFP had the greatest diagnostic value for SPE.
- Published
- 2021
22. The Prediction of Maternal Serum Alpha Fetoprotein Level and Fetal Nuchal Translucency, Forcases Involving Preterm Prelabor Rupture of Membranes
- Author
-
Yiming Chen, Yijie Chen, Lei Chen, Wenwen Ning, Xiaoying Wang, and Zhifen Zhang
- Abstract
Objective: To investigate whether the values of maternal serum alpha-fetoprotein (AFP) and fetal nuchal translucency (NT) during the first and second trimesters can predict preterm prelabor rupture of membranes (PPROM). Methods: This retrospective case-control study analyzed the first and second trimester screening indicators and maternal outcomes of gravidas who were divided into the Non-PPROM group (594) and the PPROM group (591). Binary logistic regression analysis was used to calculate the OR and 95% CI. ROC and AUC were used for screening performance of AFP and NT. Results: The values of NT and AFP in the PPROM group were higher than the control group and the difference was statistically significant (all PP>0.05). Binary logistic regression showed that NT and AFP MoM were risk factors for PPROM, with ORs of 1.719 and 3.549, respectively. The AUC according to the ROC for NT, AFP MoM and maternal weight in the first trimester +NT+AFP were 0.552, 0.618 and 0.630. Conclusions: NT and AFP during the first and second trimesters were identified as risk factors for PPROM and valuable markers to predict PPROM in late pregnancy. Multi-index joint prediction was more effective.
- Published
- 2021
23. A risk model that combines MAP, PlGF, and PAPP-A in the first trimester of pregnancy to predict hypertensive disorders of pregnancy
- Author
-
Yiming, Chen, Xue, Wang, Wensheng, Hu, Yijie, Chen, Wenwen, Ning, Sha, Lu, Pei, He, Liyao, Li, and Zhifen, Zhang
- Subjects
Hypertension, Pregnancy-Induced ,Pregnancy Trimester, First ,Pre-Eclampsia ,Predictive Value of Tests ,Pregnancy ,Case-Control Studies ,Humans ,Pregnancy-Associated Plasma Protein-A ,Arterial Pressure ,Female ,Staphylococcal Protein A ,Biomarkers ,Placenta Growth Factor ,Retrospective Studies - Abstract
Whether the first trimester maternal mean arterial pressure (MAP), placental growth factor (PlGF), and pregnancy-associated plasma protein A (PAPP-A) can predict hypertensive disorders of pregnancy (HDP) is unclear. We conducted a retrospective case-control study with the total population of 539 gravidas, of these 447 had normal pregnancy, 27 had gestational hypertension (GH), 36 had preeclampsia (PE), and 29 had preeclampsia with severe features (SPE). Prediction for HDP was determined by the area under curve (AUC). Compared to the healthy group, the multiple of the median (MoM) for MAP was increased in the study groups, while PlGF and PAPP-A were decreased. When the cutoff values for MAP, PlGF, and PAPP-A were 1.069, 0.769, and 0.673 MoM, respectively, the sensitivities for predicting HDP were 0.517, 0.446, and 0.500 and the specificities were 0.744, 0.826, and 0.769, respectively. To predict GH, the highest AUC was 0.755 (95% CI: 0.655-0.856, p 0.001) based on MAP, PlGF, and PAPP-A. The combined PlGF and PAPP-A had the highest AUC (0.683 [95% CI: 0.584-0.782, p 0.001] and 0.755 [95% CI: 0.682-0.829, p 0.001]) for prediction of PE and SPE. We found that MAP, serum levels of PlGF, and PAPP-A in the first trimester pregnancy are markers that predict HDP in the third trimester. The combination of markers is far superior to single markers alone. To improve the diagnostic value, specific cutoff values should be applied to GH, PE, SPE in each condition.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.